Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
93.07 CHF | +0.81% | +5.28% | +9.28% |
01:37pm | Legend Biotech 1Q Loss Narrows with Higher Carvykti Sales | DJ |
May. 10 | Novartis’ Scemblix Gets Third US FDA Breakthrough Therapy Designation | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.28% | 208B | |
+29.26% | 684B | |
+30.34% | 568B | |
-3.78% | 361B | |
+17.57% | 329B | |
+4.53% | 284B | |
+15.96% | 240B | |
-6.91% | 200B | |
+7.75% | 166B | |
-0.98% | 159B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Transcript : Novartis AG, 2023 Earnings Call, Jan 31, 2024